Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.55USD
14 Nov 2018
Change (% chg)

-- (--)
Prev Close
$7.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,561
52-wk High
$9.29
52-wk Low
$6.50

Latest Key Developments (Source: Significant Developments)

ImmuCell Q3 Loss Per Share $0.05
Tuesday, 13 Nov 2018 04:05pm EST 

Nov 13 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER OF 2018.Q3 LOSS PER SHARE $0.05.QTRLY TOTAL PRODUCT SALES INCREASED BY ABOUT $149,000 TO $2.2 MILLION COMPARED TO $2 MILLION DURING SAME PERIOD IN 2017, AN INCREASE OF 7%.  Full Article

ImmuCell Q2 Loss Per Share $0.15
Monday, 13 Aug 2018 04:05pm EDT 

Aug 13 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF 2018.Q2 LOSS PER SHARE $0.15.QTRLY TOTAL PRODUCT SALES INCREASED BY APPROXIMATELY $1.3 MILLION TO $3 MILLION.  Full Article

ImmuCell Announces Q4 Loss Per Share $0.04
Thursday, 8 Feb 2018 04:05pm EST 

Feb 8 (Reuters) - ImmuCell Corp ::IMMUCELL ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017.Q4 LOSS PER SHARE $0.04.PRELIMINARY QTRLY TOTAL PRODUCT SALES $3.1 MILLION VERSUS $2.2 MILLION.  Full Article

ImmuCell Corp Announces Pricing Of $3 Mln Public Offering Of Common Shares
Tuesday, 19 Dec 2017 06:30am EST 

Dec 19 (Reuters) - Immucell Corp ::IMMUCELL CORPORATION ANNOUNCES PRICING OF $3 MILLION PUBLIC OFFERING OF COMMON SHARES.IMMUCELL CORP - UNDERWRITTEN PUBLIC OFFERING OF 417,807 SHARES OF STOCK AT A PRICE TO PUBLIC OF $7.30 PER SHARE.IMMUCELL CORP - ALSO ANNOUNCED ESTIMATED REVENUES FOR TWELVE-MONTH PERIOD ENDED NOVEMBER 30, 2017 EXPECTED TO INCREASE BY 9% TO $10.2 MILLION.  Full Article

Immucell Q3 loss per share $0.07
Monday, 13 Nov 2017 04:05pm EST 

Nov 13 (Reuters) - Immucell Corp ::Immucell announces financial results for third quarter of 2017.Q3 loss per share $0.07.Immucell - ‍during 3-month period ended Sept 30, 2017, total product sales were just over $2 million versus just under $2 million during same quarter of 2016​.  Full Article

ImmuCell announces expansion of sales and marketing team
Wednesday, 13 Sep 2017 06:30am EDT 

Sept 13 (Reuters) - ImmuCell Corp :ImmuCell Corp - ‍during Q4 of 2017, company expects to achieve regulatory approval of First Defense Tri-Shield​.ImmuCell Corp - working to also achieve regulatory approval of First Defense Dual-Force, during Q4 2017.  Full Article

ImmuCell Q2 loss per share $0.05
Monday, 14 Aug 2017 04:05pm EDT 

Aug 14 (Reuters) - Immucell Corp :ImmuCell announces financial results for second quarter of 2017.Q2 loss per share $0.05.Qtrly ‍product sales $1.8 million versus $2.4 million ​.  Full Article

Immucell enters into amendment to agreement with Plas-Pak Industries
Tuesday, 25 Jul 2017 11:04am EDT 

July 25 (Reuters) - Immucell Corp ::On July 24, co entered into amendment to agreement with Plas-Pak Industries of Norwich, Connecticut, originally dated as of January 4, 2010.Says current amendment extends expiration date of agreement by three years to January 1, 2024 - SEC filing.  Full Article

No consensus analysis data available.